 |
인쇄하기
취소
|
NovoMix 30 Flexpen to be available in Korea
Novo Nordisk Korea announced on August 19 that NovoMix 30 Flexpen (reimbursable price: 11,706 won/3ml), the dual-release insulin analogue and pen system designed specifically for people starting insulin therapy, will be soon available in Korea.
NovoMix 30 Flexpen, which has been marketed in European countries plus the USA since 2002, is a unique insulin analogue combining 30 percent rapid-ac...
NovoMix 30 Flexpen, which has been marketed in European countries plus the USA since 2002, is a unique insulin analogue combining 30 percent rapid-ac...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.